Literature DB >> 29099913

Trends in the San Francisco Human Immunodeficiency Virus Epidemic in the "Getting to Zero" Era.

Susan Scheer1, Ling Hsu1, Sandra Schwarcz1, Sharon Pipkin1, Diane Havlir2, Susan Buchbinder2,3,4, Nancy A Hessol2,5.   

Abstract

Background: San Francisco has launched interventions to reduce new human immunodeficiency virus (HIV) infections and HIV-associated morbidity and mortality during the San Francisco "Getting to Zero" era. We measured recent changes in HIV care indicators to assess the success of these interventions.
Methods: San Francisco residents with newly diagnosed HIV infection, diagnosed from 2009 to 2014, were included. We measured temporal changes from HIV diagnosis to (1) linkage to care in within ≤3 months, (2) initiation of antiretroviral therapy (ART) within ≤12 months, (3) viral suppression within ≤12 months, (4) development of AIDS within ≤3 months, (5) death within ≤12 months, and (6) retention in care 6-12 months after linkage. Kaplan-Meier analyses stratified by year of HIV diagnosis measured time from diagnosis to linkage, ART initiation, viral suppression, AIDS, and death.
Results: Overall, the number of new diagnoses declined from 473 in 2009 to 329 in 2014. The proportion of new diagnoses among men (P = .005), Latinos and Asian/Pacific Islanders (P = .02), and men who have sex with men (P = .003) increased. ART initiation and viral suppression ≤12 months after diagnosis increased (P < .001), while the proportion with AIDS diagnosed ≤3 months after HIV diagnosis declined (P < .001). Time to ART initiation and time to viral suppression were significantly shorter in more recent years of diagnosis (P < .001). Time from HIV to AIDS diagnosis was significantly longer in more recent years (P < .001). Retention in care did not significantly change. Conclusions: In San Francisco new HIV diagnoses have declined and HIV care indicators have improved during the Getting to Zero era. Continued success requires attention to vulnerable populations and monitoring to adjust programmatic priorities.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29099913      PMCID: PMC6248750          DOI: 10.1093/cid/cix940

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  22 in total

1.  Durable Viral Suppression and Transmission Risk Potential Among Persons With Diagnosed HIV Infection: United States, 2012-2013.

Authors:  Nicole Crepaz; Tian Tang; Gary Marks; Michael J Mugavero; Lorena Espinoza; H Irene Hall
Journal:  Clin Infect Dis       Date:  2016-06-29       Impact factor: 9.079

2.  Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study.

Authors:  Robert M Grant; Peter L Anderson; Vanessa McMahan; Albert Liu; K Rivet Amico; Megha Mehrotra; Sybil Hosek; Carlos Mosquera; Martin Casapia; Orlando Montoya; Susan Buchbinder; Valdilea G Veloso; Kenneth Mayer; Suwat Chariyalertsak; Linda-Gail Bekker; Esper G Kallas; Mauro Schechter; Juan Guanira; Lane Bushman; David N Burns; James F Rooney; David V Glidden
Journal:  Lancet Infect Dis       Date:  2014-07-22       Impact factor: 25.071

3.  New York City Achieves the UNAIDS 90-90-90 Targets for HIV-Infected Whites but Not Latinos/Hispanics and Blacks.

Authors:  Qiang Xia; Rachael Lazar; Marie A Bernard; Paul McNamee; Demetre C Daskalakis; Lucia V Torian; Sarah L Braunstein
Journal:  J Acquir Immune Defic Syndr       Date:  2016-11-01       Impact factor: 3.731

4.  Preexposure Prophylaxis for HIV Prevention in a Large Integrated Health Care System: Adherence, Renal Safety, and Discontinuation.

Authors:  Julia L Marcus; Leo B Hurley; Charles Bradley Hare; Dong Phuong Nguyen; Tony Phengrasamy; Michael J Silverberg; Juliet E Stoltey; Jonathan E Volk
Journal:  J Acquir Immune Defic Syndr       Date:  2016-12-15       Impact factor: 3.731

5.  Vital signs: HIV prevention through care and treatment--United States.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-12-02       Impact factor: 17.586

6.  Persistent Racial Disparities in HIV Infection in the USA: HIV Prevalence Matters.

Authors:  Qiang Xia; Sarah L Braunstein; Ellen W Wiewel; James L Hadler; Lucia V Torian
Journal:  J Racial Ethn Health Disparities       Date:  2016-01-08

7.  A new trend in the HIV epidemic among men who have sex with men, San Francisco, 2004-2011.

Authors:  H Fisher Raymond; Yea-Hung Chen; Theresa Ick; Susan Scheer; Kyle Bernstein; Sally Liska; Brian Louie; Mark Pandori; Willi McFarland
Journal:  J Acquir Immune Defic Syndr       Date:  2013-04-15       Impact factor: 3.731

8.  Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies.

Authors: 
Journal:  Lancet       Date:  2008-07-26       Impact factor: 79.321

9.  Geographic Variations in Retention in Care among HIV-Infected Adults in the United States.

Authors:  Peter F Rebeiro; Stephen J Gange; Michael A Horberg; Alison G Abraham; Sonia Napravnik; Hasina Samji; Baligh R Yehia; Keri N Althoff; Richard D Moore; Mari M Kitahata; Timothy R Sterling; Frank C Curriero
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

10.  Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.

Authors:  Sheena McCormack; David T Dunn; Monica Desai; David I Dolling; Mitzy Gafos; Richard Gilson; Ann K Sullivan; Amanda Clarke; Iain Reeves; Gabriel Schembri; Nicola Mackie; Christine Bowman; Charles J Lacey; Vanessa Apea; Michael Brady; Julie Fox; Stephen Taylor; Simone Antonucci; Saye H Khoo; James Rooney; Anthony Nardone; Martin Fisher; Alan McOwan; Andrew N Phillips; Anne M Johnson; Brian Gazzard; Owen N Gill
Journal:  Lancet       Date:  2015-09-09       Impact factor: 79.321

View more
  16 in total

1.  Addressing the Sexually Transmitted Infection and HIV Syndemic.

Authors:  Monica Gandhi; Matthew A Spinelli; Kenneth H Mayer
Journal:  JAMA       Date:  2019-04-09       Impact factor: 56.272

2.  Getting to Zero San Francisco: A Collective Impact Approach.

Authors:  Susan P Buchbinder; Diane V Havlir
Journal:  J Acquir Immune Defic Syndr       Date:  2019-12       Impact factor: 3.731

3.  RAPID antiretroviral therapy: high virologic suppression rates with immediate antiretroviral therapy initiation in a vulnerable urban clinic population.

Authors:  Susa Coffey; Peter Bacchetti; Darpun Sachdev; Oliver Bacon; Diane Jones; Clarissa Ospina-Norvell; Sandra Torres; Elizabeth Lynch; Christy Camp; Remy Mercer-Slomoff; Sulggi Lee; Katerina Christopoulos; Christopher Pilcher; Ling Hsu; Chengshi Jin; Susan Scheer; Diane Havlir; Monica Gandhi
Journal:  AIDS       Date:  2019-04-01       Impact factor: 4.177

4.  Ending the HIV Epidemic: New York's Quest to Become the First State to Reduce HIV Prevalence.

Authors:  Johanne E Morne; James M Tesoriero; Erika G Martin; Guthrie S Birkhead; David R Holtgrave; Karen Hagos; Howard Zucker
Journal:  Public Health Rep       Date:  2020 Jul/Aug       Impact factor: 2.792

5.  Homelessness at diagnosis is associated with death among people with HIV in a population-based study of a US city.

Authors:  Matthew A Spinelli; Nancy A Hessol; Sandy Schwarcz; Ling Hsu; Maree-Kay Parisi; Sharon Pipkin; Susan Scheer; Diane Havlir; Susan P Buchbinder
Journal:  AIDS       Date:  2019-09-01       Impact factor: 4.177

Review 6.  Promises and challenges: cabotegravir for preexposure prophylaxis.

Authors:  Matthew A Spinelli; Beatriz Grinsztejn; Raphael J Landovitz
Journal:  Curr Opin HIV AIDS       Date:  2022-03-04       Impact factor: 4.061

7.  Simulating the End of AIDS in New York: Using Participatory Dynamic Modeling to Improve Implementation of the Ending the Epidemic Initiative.

Authors:  Erika G Martin; Roderick H MacDonald; Daniel E Gordon; Carol-Ann Swain; Travis O'Donnell; John Helmeset; Adenantera Dwicaksono; James M Tesoriero
Journal:  Public Health Rep       Date:  2020 Jul/Aug       Impact factor: 2.792

8.  Brief Report: Understanding Preferences for HIV Care Among Patients Experiencing Homelessness or Unstable Housing: A Discrete Choice Experiment.

Authors:  Madellena Conte; Ingrid Eshun-Wilson; Elvin Geng; Elizabeth Imbert; Matthew D Hickey; Diane Havlir; Monica Gandhi; Angelo Clemenzi-Allen
Journal:  J Acquir Immune Defic Syndr       Date:  2020-12-01       Impact factor: 3.771

9.  Successes and final challenges along the HIV care continuum with transwomen in San Francisco.

Authors:  Glenda N Baguso; Caitlin M Turner; Glenn-Milo Santos; H Fisher Raymond; Carol Dawson-Rose; Jess Lin; Erin C Wilson
Journal:  J Int AIDS Soc       Date:  2019-04       Impact factor: 5.396

10.  Trends in HIV incidence between 2013-2019 and association of baseline factors with subsequent incident HIV among gay, bisexual, and other men who have sex with men attending sexual health clinics in England: A prospective cohort study.

Authors:  Nadia Hanum; Valentina Cambiano; Janey Sewell; Alison J Rodger; Nneka Nwokolo; David Asboe; Richard Gilson; Amanda Clarke; Ada R Miltz; Simon Collins; Valerie Delpech; Sara Croxford; Andrew N Phillips; Fiona C Lampe
Journal:  PLoS Med       Date:  2021-06-18       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.